1. thegoldbug
2. ladygodiva9293
3. renysion
4. 49bjoe
5. dddimensions
1.davsdu94 02/14/2018
up 11.02%.
2.thegoldbug 02/26/2018
Another biotech winner so far in 2018, up 50% so far.
3.dddimensions 04/25/2018
New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors
4.49bjoe 04/11/2018
Company has initiated dosing patients in the Phase 1/2 REVEAL clinical study evaluating the efficacy and saf…
5.nomercjr 05/14/2018
Canaccord Genuity sets PT at $94
6.ladygodiva9293 06/04/2018
H.C. Wainwright Slashes Price Target on Nektar Therapeutics (NKTR), Says 'Optimism Has Been Eroded'
7.ladygodiva9293 04/11/2018
8.thegoldbug 04/16/2018
Intriguing news.
9.49bjoe 04/13/2018
Piper Jaffray resumes coverage as an overweight, $125PT
10.renysion 04/11/2018
I'm a buyer again
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW